All the information you need about MedDay Pharmaceuticals to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2021-06-24 | Partially confidential | 2020-12-31 | Complete |
| 2020-11-27 | Public | 2019-12-31 | Complete |
| 2020-11-26 | Public | 2018-12-31 | Consolidated |
| 2019-07-10 | Public | 2018-12-31 | Complete |
| 2018-10-22 | Public | 2017-12-31 | Consolidated |
| Name | MedDay Pharmaceuticals |
| Siren | 534957865 |
| Closing | 2018-12-31 |
| Registry code | 7501 |
| Registration number | 102514 |
| Management number | 2011B20170 |
| Activity code | 7211Z |
| Closing date n-1 | 2017-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2020-11-26 |
| Modification | 01 Annual accounts entered with accounting inconsistencies at document source |
| Balance sheet type | K : Consolidated |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 75008 PARIS |
| 1 - Assets (balance sheet) | Gross amount N | Amortization year N | Net year N | Net year N-1 |
AJ Other Intangible Assets | 498 000.00 | |||
AT Other tangible assets | 1 386 000.00 | |||
BH Other financial assets | 589 000.00 | |||
BJ TOTAL (I) | 2 924 000.00 | |||
BN Goods in progress | 3 610 000.00 | |||
BX Customers and related accounts | 18 192 000.00 | |||
BZ Other receivables | 6 710 000.00 | |||
CJ TOTAL (II) | 159 086 000.00 | |||
CO Grand total (0 to V) | 162 010 000.00 | |||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 161 000.00 | 160 000.00 | 161 000.00 | |
DB Share, merger, contribution premiums, etc. | 36 084 000.00 | 36 085 000.00 | 36 084 000.00 | |
DG Other reserves | 57 753 000.00 | 17 639 000.00 | 57 753 000.00 | |
DL TOTAL (I) | 129 830 000.00 | 92 737 000.00 | 129 830 000.00 | |
DX Trade payables and related accounts | 21 184 000.00 | 16 735 000.00 | 21 184 000.00 | |
DY Tax and social security liabilities | 15 000.00 | 16 174 000.00 | 15 000.00 | |
EA Other liabilities | 4 275 000.00 | 4 847 000.00 | 4 275 000.00 | |
EC TOTAL (IV) | 26 803 000.00 | 45 281 000.00 | 26 803 000.00 | |
EE Grand total (I to V) | 162 010 000.00 | 138 404 000.00 | 162 010 000.00 | |
P2 LIABILITIES - Gross Technical Reserves | 35 838 000.00 | 38 932 000.00 | 35 838 000.00 | |
P8 LIABILITIES - Profit or Loss for the Year | 18 000.00 | 18 000.00 | ||
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
GE Other Expenses | -120 000.00 | |||
GG - OPERATING RESULT (I - II) | 55 023 000.00 | |||
GV - FINANCIAL INCOME (V - VI) | 28 020 000.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | 54 995 000.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
R5 Net income of consolidated companies | 35 838 000.00 | 38 932 000.00 | 35 838 000.00 | |
R8 Net income, group share (parent company share) | 35 838 000.00 | 38 932 000.00 | 35 838 000.00 | |
